Zhitong Finance App News, Shiyao Group (01093.HK) announced that SYS 6037 injection (monkeypox mRNA vaccine), a new class 1 biological product developed by the Group in cooperation with the Institute of Microbiology of the Chinese Academy of Sciences, has been approved by the US Food and Drug Administration (FDA) and can conduct clinical trials in the US.

Zhitong Finance App News, Shiyao Group (01093.HK) announced that SYS 6037 injection (monkeypox mRNA vaccine), a new class 1 biological product developed by the Group in cooperation with the Institute of Microbiology of the Chinese Academy of Sciences, has been approved by the US Food and Drug Administration (FDA) and can conduct clinical trials in the US.